Apyx Medical Corp
APYX
Get informed when a big investor buys or sells
+ FollowMarket Cap$183.57M
Close$
$-4.10
197.2% downside
Current Fair Value
197.2% downsideOvervalued by 197.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $183.57 Million |
|---|---|
| Enterprise Value | $156.81 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.27 |
| Beta | 1.37 |
| Outstanding Shares | 42,163,000 |
Return
| Return on Equity | -71.45% |
|---|---|
| Return on Assets | -14.55% |
| Return on Invested Capital | -9.81% |
Valuation & Multiples
| P/E Ratio | -19.68 |
|---|---|
| PEG | 39.99 |
| Price to Sales | 4.22 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.81 |
| Enterprise Value to EBIT | -29.83 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.34 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$10.78 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$13.18 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.47%▼ 46.89% |
|---|---|
| Total Invested | $4.67M▼ 93.92% |
| Investors Holding | 1▼ 67.00% |
ESG Score
No data
About Apyx Medical Corp
CEO: Charles Goodwin